Literature DB >> 26744064

Study on colorectal cancer presentation, treatment and follow-up.

Muhammad Aakif1, Paul Balfe2, Osama Elfaedy2, Faisal Nazir Awan2, Friedrick Pretorius2, Leonardo Silvio2, Constantino Castinera2, Hamid Mustafa2.   

Abstract

BACKGROUND: Colorectal carcinoma (CRC) is the second most common cancer in women and men affecting 9.7 % population worldwide. Although CRC mortality has been progressively declining since 1990 at a rate of about 3 % per year, it still remains the third most common cause of cancer deaths.
OBJECTIVE: The objective of this study is to evaluate the patterns of clinical presentation, treatment options and follow-up of colorectal carcinoma.
METHODOLOGY: Medical records of patients with colorectal carcinoma admitted at St. Luke's Hospital Kilkenny from January 2009 to December 2014 were included in the study.
RESULTS: Out of 113, 57 were males and 28 were 75 years or older. Sixty-seven percent presented in the outpatient clinic. The main presentation symptom was bleeding per rectum (40 %), followed by abdominal pain, altered bowel habit, bowel obstruction and weight loss. Mean time delay was 4.79, 6.20 and 4.83 weeks for surgical outpatient department (SOPD), colonoscopy and surgery, respectively. Ninety-eight percent of patients underwent preoperative staging with computed tomography of thorax, abdomen and pelvis (CTTAP) and 78 % had preoperative carcinoembryonic antigen (CEA) measurement. Thirty-four percent of cancers had already metastasized to distant organs. Twenty five percent underwent a right hemicolectomy. Seventy-eight percent received a primary anastomosis. Ninety-five percent achieved a R0 resection. Sixty-two percent were given adjuvant chemotherapy. Seventy-six percent had surgery follow-up and 57 % had excellent follow-up. Cancer recurred in two patients. Thirty day mortality was 2 %.
CONCLUSION: Our study shows that the mean age group at risk for colorectal cancer is 65 years (range 54-75). Still, 33 % of patients present to acute surgical assessment units with advanced disease. Though we did well in terms of operative resections, follow-up still remains a challenge.

Entities:  

Keywords:  Colorectal cancer; Colorectal carcinoma; Follow-up; Surgical outpatient department

Mesh:

Year:  2016        PMID: 26744064     DOI: 10.1007/s00384-015-2479-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  5 in total

1.  Readmissions after colorectal surgery: not all are equal.

Authors:  Laura Z Hyde; Ahmed M Al-Mazrou; Ben A Kuritzkes; Kunal Suradkar; Neda Valizadeh; Ravi P Kiran
Journal:  Int J Colorectal Dis       Date:  2018-08-30       Impact factor: 2.571

2.  Hedyotis diffusa willd extract suppresses colorectal cancer growth through multiple cellular pathways.

Authors:  Jianyu Feng; Yiyi Jin; Jun Peng; Lihui Wei; Qiaoyan Cai; Zhaokun Yan; Zijun Lai; Jiumao Lin
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

3.  Pinin facilitated proliferation and metastasis of colorectal cancer through activating EGFR/ERK signaling pathway.

Authors:  Zhigang Wei; Wenhui Ma; Xiaolong Qi; Xianjun Zhu; Yutian Wang; Zhuoluo Xu; Jun Luo; Da Wang; Weihong Guo; Xiaomei Li; Sainan Xin; Jiang Yu; Guoxin Li
Journal:  Oncotarget       Date:  2016-05-17

Review 4.  Caffeine and its main targets of colorectal cancer.

Authors:  Wen-Qi Cui; Shi-Tong Wang; Dan Pan; Bing Chang; Li-Xuan Sang
Journal:  World J Gastrointest Oncol       Date:  2020-02-15

5.  In vivo and in vitro induction of the apoptotic effects of oxysophoridine on colorectal cancer cells via the Bcl-2/Bax/caspase-3 signaling pathway.

Authors:  Shao-Ju Jin; Yun Yang; Lei Ma; Ben-Hui Ma; Li-Ping Ren; Liu-Cheng Guo; Wen-Bao Wang; Yan-Xin Zhang; Zhi-Jun Zhao; Mingchen Cui
Journal:  Oncol Lett       Date:  2017-10-19       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.